Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00152
   Synonyms CYTOR, C2orf59, LINC00152, NCRNA00152, MGC4677
   Region GRCh38_2:87454781-87636740    Sequence
   Ensembl ENSG00000222041
   RefSeq NR_024204
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colorectal cancer
   ICD-0-3 C19.9  
   Methods qPCR, Western blot, etc.
   Sample 80 human CRC tissue samples, 40 non?cancerous tissue samples. CRC cell lines (SW480, SW620 , LoVo).
   Expression Pattern down-regulation
   Function Description

Collectively, these findings demonstrate the critical role of lnc00152 in tumor growth and progression in CRC, and identify a novel therapeutic target associated with CRC development and progression. Kaplan?Meyer overall survival curves display higher lnc00152 levels in patients with colorectal cancer (CRC) with lower survival times (log?rank test, P=0.047). However, further clarifications of the systemic correlation between miRNAs and lncRNAs are required.

   Pubmed ID 29956750
   Year 2018
   Title Long non?coding RNA 00152 functions as a competing endogenous RNA to regulate NRP1 expression by sponging with miRNA?206 in colorectal cancer.
   External Links
   Links for  LINC00152 GenBank       HGNC       lncrnadb       Noncode
   Links for  colorectal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.